Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts� ("tumor xenograft") that is being developed by researchers at Champion.
Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts™ (“tumor xenograft”) that is being developed by researchers at Champion.